Clinical Trial

An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis

Study acronym: PROSECT RP
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Open label pragmatic two-stage non-randomized trial comparing the effectiveness of five different standard of care treatment options for patients with relapsing polychondritis (RP).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-15; most recent amendment 2026-02-03.
Status change: Not Yet Recruiting → Recruiting 2025-09-16
Trial Details
NCT Number NCT06941376
Lead Sponsor University of Pennsylvania
Conditions Relapsing Polychondritis
Enrollment 20 participants
Start Date 2025-08-01
Primary Completion 2027-07 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-04